Results 291 to 300 of about 8,989,140 (356)
Some of the next articles are maybe not open access.
The Newly Qualified Nurse’s Survival Guide, 2012
The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention, Drug Safety advances the rational use of pharmacotherapy by publishing ...
J. Hole, Moira Davies
openaire +2 more sources
The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention, Drug Safety advances the rational use of pharmacotherapy by publishing ...
J. Hole, Moira Davies
openaire +2 more sources
Legacy data sharing to improve drug safety assessment: the eTOX project
Nature Reviews Drug Discovery, 2017F. Sanz +35 more
semanticscholar +3 more sources
, 2020
With excessive and inappropriate use of medicines amongst the Pakistani population, an unforeseen medicine safety problem can rapidly escalate to become a large-scale, major public health hazard.
M. Atif +5 more
semanticscholar +1 more source
With excessive and inappropriate use of medicines amongst the Pakistani population, an unforeseen medicine safety problem can rapidly escalate to become a large-scale, major public health hazard.
M. Atif +5 more
semanticscholar +1 more source
Pharmacoepidemiology and Drug Safety, 2019
To examine the potential role of Medical Information Database Network (MID‐NET®), a newly established Japanese medical information database network, in postmarketing drug safety assessments through the characterization of its advantages and limitations ...
Kaori Yamada +13 more
semanticscholar +1 more source
To examine the potential role of Medical Information Database Network (MID‐NET®), a newly established Japanese medical information database network, in postmarketing drug safety assessments through the characterization of its advantages and limitations ...
Kaori Yamada +13 more
semanticscholar +1 more source
Drug safety, drug quality, drug analysis
Journal of Pharmaceutical and Biomedical Analysis, 2008Controlling and minimizing the side effects of drugs are the key issues in assuring the safety of drug therapy. Since side effects are inherent properties of the drug material, these cannot be influenced by drug analysts. At the same time drug analysts play a predominant role in assuring the quality of bulk drug materials and drug formulations and this
openaire +2 more sources
2010
The occurrence of sometimes life-threatening adverse drug reactions (ADRs) jeopardizes patients’ health during drug treatment and additionally imposes an increased financial burden on the healthcare system. The withdrawal of already marketed drugs because of ADRs furthermore erodes public confidence in the way drugs are approved.
openaire +1 more source
The occurrence of sometimes life-threatening adverse drug reactions (ADRs) jeopardizes patients’ health during drug treatment and additionally imposes an increased financial burden on the healthcare system. The withdrawal of already marketed drugs because of ADRs furthermore erodes public confidence in the way drugs are approved.
openaire +1 more source
Current Pharmaceutical Design, 2012
The operating room offers a unique setting where anesthetics, preoperative medications, patient comorbidities, and surgery all merge. Anesthesiologists are responsible for combining these concerns into a dependable and safe approach. From formulation to administration, enhancements in nearly every aspect of a given drug have improved the ability of ...
J Adam, Cartwright +5 more
openaire +2 more sources
The operating room offers a unique setting where anesthetics, preoperative medications, patient comorbidities, and surgery all merge. Anesthesiologists are responsible for combining these concerns into a dependable and safe approach. From formulation to administration, enhancements in nearly every aspect of a given drug have improved the ability of ...
J Adam, Cartwright +5 more
openaire +2 more sources
Expert Opinion on Drug Safety, 2005
The safety of obesity drugs has historically been poor. This and the stigmatisation of obesity in society ensured that a higher standard of safety for obesity drugs must be met. The authors review the safety disasters of obesity drugs that were withdrawn.
Frank L, Greenway, Mary K, Caruso
openaire +2 more sources
The safety of obesity drugs has historically been poor. This and the stigmatisation of obesity in society ensured that a higher standard of safety for obesity drugs must be met. The authors review the safety disasters of obesity drugs that were withdrawn.
Frank L, Greenway, Mary K, Caruso
openaire +2 more sources
JAMA, 1964
NOW, BY LAW, new drugs must be both effective and relatively safe. But I think a new drug must be more than a tolerable cipher in an already overcrowded list. The hope of significant new knowledge which may lead to therapeutic progress is, in my view, the only defense for studying the effects of as yet poorly understood new drugs in human subjects. How
openaire +2 more sources
NOW, BY LAW, new drugs must be both effective and relatively safe. But I think a new drug must be more than a tolerable cipher in an already overcrowded list. The hope of significant new knowledge which may lead to therapeutic progress is, in my view, the only defense for studying the effects of as yet poorly understood new drugs in human subjects. How
openaire +2 more sources
The American Journal of Cardiology, 2007
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. This led to early adoption and high penetration of DES use in percutaneous coronary intervention (PCI). Outcomes have not demonstrated an improvement in the hard end points of death and myocardial infarction with these devices, but repeat procedures for ...
Tina L Pinto, Slottow, Ron, Waksman
openaire +2 more sources
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. This led to early adoption and high penetration of DES use in percutaneous coronary intervention (PCI). Outcomes have not demonstrated an improvement in the hard end points of death and myocardial infarction with these devices, but repeat procedures for ...
Tina L Pinto, Slottow, Ron, Waksman
openaire +2 more sources